Deinove to establish new subsidiary for antibiotics program
The Holding Incubator Green Chemistry, which has invested € 0.5m, will hold 51% of Deinobiotics while Deinove 49%. Deinove CEO Emmanuel Petiot said, "Our priority at DEINOVE is
The Holding Incubator Green Chemistry, which has invested € 0.5m, will hold 51% of Deinobiotics while Deinove 49%. Deinove CEO Emmanuel Petiot said, "Our priority at DEINOVE is
The legal action, initiated by Dr. Reddy’s in New Jersey, related to certain bioequivalence studies by the former MDS Pharma Services business unit from 1 January 2000 to
The Duke clinical research unit is the early phase unit of the Duke Clinical Research Institute. Benitec chief executive officer Peter French said, "The TT-034 trial marks the
The research will leverage Tokyo Tech’s TSUBAME2.0 supercomputer for the discovery of drugs for patients suffering from dengue fever/dengue hemorrhagic fever. The first step of the collaborative research
The low-volume viscosupplement product was approved as a pain reliever that improves knee joint function in a single injection. Zimmer senior vice president David Nolan said, "Gel-One Hyaluronate
NEB is a privately held company focused on the discovery and production of enzymes for molecular biology applications in the life science industry. The Singapore office general manager
The firm, in the first quarter of 2012, had initially implemented the software’s first phase, which aims to comply with new short cycle dispensing regulations that requires 14-day
Quito-based Takeda Ecuador will carry out sales and marketing operations of the company’s products in the region. Carlos Haro who previously served as general manager for Sanofi, is
Cartagenia’s BENCHlab CNV solution helps labs to deploy microarray testing for prenatal diagnosis, as well as a seamless transition from prenatal to continued post-natal follow-up. The product will
DMD is a pediatric rare disease that affects approximately one in 3,600 boys worldwide, and is caused by a genetic mutation that renders boys unable to make functional